ESR1 and breast cancer: This concept is supported by experimental evidence indicating that probiotic-conditioned media selectively impairs the viability of estrogen receptor-positive (ER+) breast cancer cells and differentially modulates mitochondrial metabolic activity in non-malignant epithelial cells, potentially through β-glucuronidase (GUS)-mediated mechanisms [106,107].